MapLight Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MapLight Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $92.00K, a 2966.67% increase year-over-year.
- MapLight Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.00K, a 80.00% decline year-over-year.
- MapLight Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $183.00K, a 2514.29% increase year-over-year.
- MapLight Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $3.00K, a 66.67% decline year-over-year.
- MapLight Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $285.00K, a 3.06% decline from fiscal 2024.
- MapLight Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $294.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $92.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $285.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $183.00K 10-Q · filed 2025-12-04 | |
| 2025-06-30 | $3.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $5.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $294.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $7.00K 10-Q · filed 2025-12-04 | |
| 2024-06-30 | $9.00K 10-Q · filed 2025-12-04 | |
| 2024-03-31 | $256.00K 10-Q · filed 2025-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |